CliffBio
small molecule

MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM

DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM

Loss of exclusivityOctober 2036latest FDA-listed patent expiry
CompanyRB HEALTH US LLC

Drug detail

Brand nameMUCINEX 12HR COLD & FEVER MULTI-SYMPTOM
Active ingredientDEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM
Strength30MG;600MG;110MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2025
Marketing statusOTC

Listed patents

PatentExpiresType
12257218October 2036product
12370189October 2036product
11278506October 2036product

More from RB HEALTH US LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM patent cliff — loss of exclusivity October 2036 | CliffBio